Easy to Use
Rapid Results in 10 Minutes
Requires No Additional Equipment
ImmunoPass™ SARS-Cov-2 Neutralizing Antibody (NAb) Rapid Test is a rapid lateral flow chromatographic immunoassay intended for the sem-iquantitative measurement of neutralizing antibody in human serum or plasma (sodium heparin, potassium and acid dextrose citrate).
The ImmunoPass™ SARS-Cov-2 Neutralizing Antibody (NAb) Rapid Test measures functional neutralizing antibodies (NAbs) within 10 minutes, unlike traditional test which require days. The ImmunoPass™ test kit does not utilize live biological materials and does not require the strict biosafety protocol associated with live virus samples.
The ImmunoPass™ Neutralizing Antibody (NAb) test demonstrates the ability of antibodies to BLOCK the binding of the RBD on spike protein to ACE2, the cellular receptor. RBD is the principle neutralizing determinant for SARS-CoV-2.
Why Are Neutralizing Antibodies important?
The ImmunoPass™ Neutralizing Antibody (NAb) Rapid Test is intended for semi-quantitative measurement of neutralizing antibody levels in plasma or serum from individuals who have had recent or prior infection with SARS-CoV-2 and who have recovered from COVID-19. This product is intended for use as a clinical decision-making tool for therapeutic administration of convalescent plasma for treatment of patients fighting COVID-19. The Test is for professional use only.
Allow the test cassette, specimen, buffer, and/or controls to reach room temperature (15-30°C) prior to testing.
Clean finger with the Alcohol Wipe
Pierce skin with spring-loaded Lancet
Touch Pipette tip to blood drop. DO NOT SQUEEZE
Squeeze capillary to expel sample into test port. Wait 20 seconds to allow the blood to be absorbed
Add 2 drops of buffer solution. Read results at 10 minutes*. Reference NAb Results Key.
HIGH VIRUS-NEUTRALIZING ACTIVITY. No visible or near-transparent line indicates a high neutralizing antibody immunity response to COVID-19.
MODERATELY HIGH VIRUS-NEUTRALIZING ACTIVITY. A visible faint line, indicates a moderately high neutralizing antibody immunity response to COVID-19.
MODERATE VIRUS-NEUTRALIZING ACTIVITY. An easily noticeable test line, indicates a moderate neutralizing antibody immunity response to COVID-19.
NO VIRUS-NEUTRALIZING ACTIVITY. A Bold green test line, indicates no or a very low neutralizing antibody immunity response to COVID-19.